1. Identification of AR-V7 downstream genes commonly targeted by AR/AR-V7 and specifically targeted by AR-V7 in castration resistant prostate cancer
   Masahiro Sugiura et al, 2021, Translational Oncology CrossRef
2. Hsa_circ_0050900 affects ferroptosis in intrahepatic cholangiocarcinoma cells by targeting hsa‑miR-605‑3p to regulate SLC3A2
   Xiangtian Shi et al, 2023, Oncology Letters CrossRef
3. Identification of DNA aptamers that specifically targets EBV+ nasopharyngeal carcinoma via binding with EphA2/CD98hc complex
   Yaqi Chen et al, 2022, Biochemical and Biophysical Research Communications CrossRef
4. The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes
   Rokaya El Ansari et al, 2018, British Journal of Cancer CrossRef
5. xCT-Driven Expression of GPX4 Determines Sensitivity of Breast Cancer Cells to Ferroptosis Inducers
   Namgyu Lee et al, 2021, Antioxidants CrossRef
6. CD98 heavy chain as a prognostic biomarker and target for cancer treatment
   Pu Xia et al, 2023, Frontiers in Oncology CrossRef
7. ZEB1 Promotes Chemoresistance to Cisplatin in Ovarian Cancer Cells by Suppressing SLC3A2
   Yajie Cui et al, 2018, Chemotherapy CrossRef
8. Functional role of MicroRNA/PI3K/AKT axis in osteosarcoma
   Yubo Xiang et al, 2023, Frontiers in Oncology CrossRef
9. An Emerging Class of Long Non-coding RNA With Oncogenic Role Arises From the snoRNA Host Genes
   Alina-Andreea Zimta et al, 2020, Frontiers in Oncology CrossRef
10. In Vitro and In Vivo Comparative Analysis of Differentially Expressed Genes and Signaling Pathways in Breast Cancer Cells on Interaction with Mesenchymal Stem Cells
    Hariharan Jayaraman et al, 2023, Applied Biochemistry and Biotechnology CrossRef
11. SLC3A2 inhibits ferroptosis in laryngeal carcinoma via mTOR pathway
    Fangxing Wu et al, 2022, Hereditas CrossRef
12. MIF/SCL3A2 depletion inhibits the proliferation and metastasis of colorectal cancer cells via the AKT/GSK‐3β pathway and cell iron death
    Guan Huang et al, 2022, Journal of Cellular and Molecular Medicine CrossRef
13. Hypoxia-inducible factor-1 promotes cancer progression through activating AKT/Cyclin D1 signaling pathway in osteosarcoma
    Bo Zhang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
14. Characterizing the role of SLC3A2 in the molecular landscape and immune microenvironment across human tumors
    Jiajun He et al, 2022, Frontiers in Molecular Biosciences CrossRef
15. The heavy chain of 4F2 antigen promote prostate cancer progression via SKP-2
    Maihulan Maimaiti et al, 2021, Scientific Reports CrossRef
16. Alloferon Affects the Chemosensitivity of Pancreatic Cancer by Regulating the Expression of SLC6A14
    Hyejung Jo et al, 2022, Biomedicines CrossRef
17. Downregulation of SLC3A2 mediates immune evasion and accelerates metastasis in oral squamous cell carcinoma
    Jiang En Wu et al, 2024, Journal of Cellular and Molecular Medicine CrossRef
18. Overexpression of membranal SLC3A2 regulates the proliferation of oral squamous cancer cells and affects the prognosis of oral cancer patients
    Jiayu Liang et al, 2021, Journal of Oral Pathology & Medicine CrossRef
19. Identification of a Solute Carrier Family-Based Signature for Predicting Overall Survival in Osteosarcoma
    Di Zheng et al, 2022, Frontiers in Genetics CrossRef
20. Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma
    Laura D. Gamble et al, 2019, Science Translational Medicine CrossRef
21. Role of ferroptosis in esophageal cancer and corresponding immunotherapy
    Xin Fan et al, 2023, World Journal of Gastrointestinal Oncology CrossRef